SEC Form 4 · accession 0001127602-15-032546
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark D Snyder
Officer — EVP Mfg. Ops & Business System
Period of report
Nov 23, 2015
Accepted (ET)
Nov 25, 2015 · 9:55 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 23, 2015 | M | 8,000 | $27.63 | A | 19,249 | D | |
| Common Stock | Nov 23, 2015 | F | 5,955 | $42.36 | D | 13,294 | D | |
| Common Stock | Nov 23, 2015 | M | 2,000 | $26.09 | A | 15,294 | D | |
| Common Stock | Nov 23, 2015 | F | 1,436 | $42.36 | D | 13,858 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F1 | $27.63 | Nov 23, 2015 | M | 8,000 | D | — | Jun 1, 2021 | Common Stock | 8,000 | 2,000 | D |
| Sars (Stock Appreciation Rights)F1 | $26.09 | Nov 23, 2015 | M | 2,000 | D | — | Jun 1, 2022 | Common Stock | 2,000 | 8,000 | D |
Explanation of responses
- F1The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.